News Numinus Wellness launches new psychedelics clinic licensing model for independent practitioners The company also partnered with Healing CREI to offer full operational clinics to their licensees Natalia Buendia CalvilloApril 11, 2023
Canada Numinus launches ketamine-assisted therapy in Toronto Neurology Centre of Toronto in Forest Hill expands its therapy catalogue Rowan DunneSeptember 21, 2022
Canada DOSED 2 screening sells out at Vancouver’s Rio Theatre Film screening was followed by audience Q&A session hosted by director Rowan DunneSeptember 13, 2022
Business Numinus reports sequential revenue dip of 5.7% The drop was due to a shift in Numinus Bioscience operations Natalia Buendia CalvilloJuly 15, 2022
Business Numinus completes Novamind acquisition, upgrades leadership team Novamind's clinics in Utah and Arizona will continue to operate as their current brand until later this year Natalia Buendia CalvilloJune 14, 2022
Culture Numinus announces Music as Medicine event series Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy Ryan GarnerMay 3, 2022
Business Recent acquisitions help Numinus bolster revenue 240 per cent year-over-year Numinus' gross margin improved to 29.1 per cent during Q2 2022 following acquisitions of Mindspace Psychology Services Inc. and the Neurology Centre of Toronto Ryan GarnerApril 19, 2022
Business Numinus to enter US psychedelics market via $26.2M Novamind acquisition The transaction is expected to close around June Natalia Buendia CalvilloApril 12, 2022
Business Numinus approved to study ayahuasca and San Pedro in Canada Used in sacred traditions for centuries, the firm says research will bring their medicinal benefits to a larger audience Natalia Buendia CalvilloMarch 9, 2022
Business Numinus uplists to OTCQX Best Market Stock will start trading at market open Thursday under the symbol NUMIF Natalia Buendia CalvilloJanuary 26, 2022